These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29696565)

  • 1. Emerging role of semaphorin-3A in autoimmune diseases.
    Liu LN; Li XM; Ye DQ; Pan HF
    Inflammopharmacology; 2018 Jun; 26(3):655-665. PubMed ID: 29696565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semaphorin 3A - a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus.
    Vadasz Z; Toubi E
    Lupus; 2012 Oct; 21(12):1266-70. PubMed ID: 22875653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.
    Catalano A
    J Immunol; 2010 Nov; 185(10):6373-83. PubMed ID: 20937848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorin 3A: an immunoregulator in systemic sclerosis.
    Rimar D; Nov Y; Rosner I; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Vadasz Z
    Rheumatol Int; 2015 Oct; 35(10):1625-30. PubMed ID: 25895648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
    Costa C; Martínez-Sáez E; Gutiérrez-Franco A; Eixarch H; Castro Z; Ortega-Aznar A; Ramón Y Cajal S; Montalban X; Espejo C
    Mult Scler; 2015 Nov; 21(13):1632-43. PubMed ID: 26432853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus.
    Vadasz Z; Haj T; Halasz K; Rosner I; Slobodin G; Attias D; Kessel A; Kessler O; Neufeld G; Toubi E
    Arthritis Res Ther; 2012 Jun; 14(3):R146. PubMed ID: 22697500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus.
    Eiza N; Sabag AD; Kessler O; Neufeld G; Vadasz Z
    J Autoimmun; 2023 Jan; 134():102960. PubMed ID: 36470209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus.
    Wang P; Mao YM; Liu LN; Zhao CN; Li XM; Pan HF
    Immunol Invest; 2020 Feb; 49(1-2):69-80. PubMed ID: 31412748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of air pollution in autoimmune diseases.
    Zhao CN; Xu Z; Wu GC; Mao YM; Liu LN; Qian-Wu ; Dan YL; Tao SS; Zhang Q; Sam NB; Fan YG; Zou YF; Ye DQ; Pan HF
    Autoimmun Rev; 2019 Jun; 18(6):607-614. PubMed ID: 30959217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological Stress, Intestinal Barrier Dysfunctions, and Autoimmune Disorders: An Overview.
    Ilchmann-Diounou H; Menard S
    Front Immunol; 2020; 11():1823. PubMed ID: 32983091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaphorin 3A: A new player in bone remodeling.
    Xu R
    Cell Adh Migr; 2014; 8(1):5-10. PubMed ID: 24589620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine semaphorin 3A signaling promotes glioblastoma dispersal.
    Bagci T; Wu JK; Pfannl R; Ilag LL; Jay DG
    Oncogene; 2009 Oct; 28(40):3537-50. PubMed ID: 19684614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of Semaphorin 3A with thrombocytopenia in systemic lupus erythematosus].
    Guo Q; Ma XX; Gao H; Shi LJ; Zhong YC; Xie LF; Shao M; Zhang XW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):892-896. PubMed ID: 33047725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic dysregulation of lymphocytes in autoimmune diseases.
    Wang S; Yang N; Zhang H
    Trends Endocrinol Metab; 2024 Jul; 35(7):624-637. PubMed ID: 38355391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semaphorin 3A-mediated axon guidance regulates convergence and targeting of P2 odorant receptor axons.
    Schwarting GA; Raitcheva D; Crandall JE; Burkhardt C; Püschel AW
    Eur J Neurosci; 2004 Apr; 19(7):1800-10. PubMed ID: 15078553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorin and neuropilin co-expression in motoneurons sets axon sensitivity to environmental semaphorin sources during motor axon pathfinding.
    Moret F; Renaudot C; Bozon M; Castellani V
    Development; 2007 Dec; 134(24):4491-501. PubMed ID: 18039974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer.
    Müller MW; Giese NA; Swiercz JM; Ceyhan GO; Esposito I; Hinz U; Büchler P; Giese T; Büchler MW; Offermanns S; Friess H
    Int J Cancer; 2007 Dec; 121(11):2421-33. PubMed ID: 17631638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria.
    Doron R; Merav L; Nasrin E; Adi SD; Elias T; Gleb S; Itzhak R; Michael R; Zahava V
    Inflammation; 2022 Apr; 45(2):603-609. PubMed ID: 34562225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible involvement of sema3A and sema4A in the pathogenesis of multiple sclerosis.
    Eiza N; Garty M; Staun-Ram E; Miller A; Vadasz Z
    Clin Immunol; 2022 May; 238():109017. PubMed ID: 35460904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H4 Modulates Regulatory CD4
    Podojil JR; Chiang MY; Ifergan I; Copeland R; Liu LN; Maloveste S; Langermann S; Liebenson D; Balabanov R; Chi H; Chen L; Vignali DAA; Miller SD
    J Immunol; 2018 Aug; 201(3):897-907. PubMed ID: 29898965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.